Kaposi sarcoma in a patient treated with ruxolitinib
Author:
Funder
Associazione Italiana per la Ricerca sul Cancro
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/28/7/1670/17928324/mdx188.pdf
Reference5 articles.
1. Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis?;Heine;Blood,2013
2. Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease;Spoerl;Blood,2014
3. A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea;Verstovsek;Cancer,2014
4. JAK inhibition impairs NK cell function in myeloproliferative neoplasms;Schonberg;Cancer Res,2015
5. Rapid and long-lasting decrease of T-regulatory cells in patients with myelofibrosis treated with ruxolitinib;Massa;Leukemia,2014
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Kaposi sarcoma in a patient treated with upadacitinib for rheumatoid arthritis;JAAD Case Reports;2023-09
2. Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives;International Journal of Hematology;2022-03-29
3. Kaposi's sarcoma, biologics and small molecules: Navigating the complex interplay between host immunity and viral biology. A case series with focused review of the literature;Dermatologic Therapy;2021-12-27
4. The JAK/STAT signaling pathway: from bench to clinic;Signal Transduction and Targeted Therapy;2021-11-26
5. Iatrogenic Kaposi's sarcoma in a myelofibrosis patient treated with ruxolitinib: Case‐report , literature review, and French pharmacovigilance data;American Journal of Hematology;2021-11-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3